Betta Pharmaceuticals Co., Ltd. (SZSE: 300558)
Health Care · Pharmaceuticals · CN
CN¥51.18
-25.49% today · -29.7% 1Y
Betta Pharmaceuticals Co., Ltd. (SZSE: 300558) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.20B and employs 1,785 people.
Over the last twelve months the share price has lost 29.7%, trading between 40.10 and 79.80.
Tweenvest scores Betta Pharmaceuticals Co., Ltd. across four factors: quality 69/100, value 55/100, growth 41/100, dividend 7/100. Its strongest factor is quality.
300558 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.20B
- Revenue (TTM)
- $567.34M
- P/E
- 45.87
- EPS
- 1.12
- Dividend yield
- 0.29%
- Beta (5Y)
- 0.45
- 52-week high
- CN¥79.80
- 52-week low
- CN¥40.10
- Avg volume (3M)
- —
- Shares outstanding
- 420.73M
- Employees
- 1,785
- Next earnings
- —
About Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized in the management of non-small-cell lung cancer. Founded in 2003, the firm is headquartered in Hangzhou, China.
- ISIN
- CNE100002DD9
- Founded
- 2003
- Listed since
- Nov 9, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.